Harvard Bioscience (HBIO) Misses Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q3 EPS of ($0.02), $0.04 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $21.97 million versus the consensus estimate of $23.7 million.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rockstar Energy founder seeks CEO role at Celsius Holdings
- Artiva Biotherapeutics, Inc. (ARTV) Misses Q2 EPS by 63c
- bioAffinity (BIAF) Tops Q2 EPS by 146c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
